Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults

Clinical trial NCT00259831 · COMPLETED

Trial details

NCT number: NCT00259831
Sponsor: CV Technologies
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Upper Respiratory Infection

Start date: 2005-12-01
Primary completion: 2006-06-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.